Heparan sulfate: <i>In vitro</i> and <i>in vivo</i> proof of efficacy of this new therapeutic strategy for halting Alzheimer disease‐related tauopathy developmentAuriane Maïza, Dulce Papy-García, Aida Muntsant Soria et al.|Alzheimer s & Dementia|2021Cited by 0